DICE INCIDENCE CAPTURE: Determinants, Incidence, and consequences of Corticosteroid Excess in IBD
- Conditions
- K50Crohn disease [regional enteritis]K51Ulcerative colitis
- Registration Number
- DRKS00025270
- Lead Sponsor
- AbbVie Deutschland GmbH & Co. KG
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 2635
Inclusion Criteria
Patients diagnosed with IBD >1year
Patient attending IBD clinic visit (or clinical assessments performed by phone/web, where applicable)
Exclusion Criteria
Suspected but not yet confirmed IBD
Post-colectomy UC patients with no evidence for Crohn's disease
Patients <18 years old
Patients receiving investigational products and enrolled in clinical studies
Any of the following conditions:
Solid organ transplantation (any), adrenal insufficiency/Addison’s disease/hypopituitarism,
Autoimmune hepatitis, Polymyalgia rheumatica,
Uveitis, Systemic lupus erythematousus, Rheumatoid arthritis, Giant cell arteritis, Vasculitis (various subtypes/pseudonyms), haemolytic anaemia
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method